Skip to main content

Available Courses

A Race Against Time: Accelerating the Adoption of GDMT in Heart Failure
  • Not accredited

Learning objectives

  • Recall guideline recommendations for the use of NT-proBNP in heart failure
  • Describe current practices in heart failure diagnosis and the impact on treatment outcomes
  • Develop an optimised approach to the timely diagnosis and management of heart failure
See more
Achieving Lipid Targets & Managing CV Risk: Reassessing our way with Statins
  • 1.00 EBAC

Learning objectives

  • Recall prevalence of patients who are statin uncontrolled/intolerant
  • Define the additive benefit of combination treatment compared with statin intensification
  • Name the non-statin LLTs offering proven CV protection
  • Identifying patients with indication for novel non-statin therapy
  • Initiate lipid-lowering strategies proven to lower future CV events
See more
Advanced Approaches to Combined Epicardial and Endocardial Strategies – From New Consensus to Practice
  • 1.00 EBAC

Learning objectives

  • Identify patient populations who may benefit from hybrid ablation
  • Summarise the existing rationale and evidence for hybrid ablation beyond atrial fibrillation
  • Understand how to integrate left atrial appendage exclusion in atrial ablation approaches
  • Examine key aspects of new consensus recommendations for hybrid ablation
See more
Advancing Patient Care in Hypertrophic Cardiomyopathy
  • 0.50 AMA PRA Credit

Learning objectives

  • Recall recent trial data for novel disease modifying therapy in HCM
  • Describe the evolving guideline directed approach to managing HCM
  • Develop an expert-led approach to implementing novel therapy in clinical practice
See more
AF Stroke Prevention – Applying New Guidance in the Real World
  • 1.00 EBAC

Learning objectives

  • Recall the risk of ischaemic stroke in AF patients
  • Compare therapeutic efficacy and risk between left atrial appendage closure and oral anticoagulation in atrial fibrillation
  • Review European guideline updates on the use of left atrial appendage closure in atrial fibrillation
  • Summarise the clinical evidence behind non-pharmacological approaches to stroke prevention in atrial fibrillation
See more
An Expert Approach to Cardio-Renal Protection in CKD
  • 2.00 EBAC

Learning objectives

  • Recall clinical evidence and guidelines for the management of CKD patients without diabetes
  • Describe current gaps and barriers in evidence-based management for CKD without diabetes
  • Apply evidence based-management strategies to a case study
  • Use expert-led guidance to develop an optimal management approach to CKD patients without diabetes
See more
Bridging the Gap in Worsening Heart Failure: Evidence-Based Approaches to Optimising Treatment Outcomes
  • 1.25 AMA PRA Credit

Learning objectives

  • To identify high-risk patient features indicative of worsening Heart Failure (HF)
  • Name validated tools for serial prognostic assessment and risk stratification
  • Adopt the use of appropriate assessment tools during patient follow-up
  • Recall rates of recurrent HF events and their associated healthcare costs in worsening HF patients
  • Recall the clinical benefit of emerging treatments targeted to treating worsening HF
  • Initiate available treatment for the tailored management of worsening HF
See more
Cardiac Amyloidosis: Emerging Diagnostic and Treatment Approaches
  • 1.00 EBAC

Learning objectives

  • Understand the nature of amyloidosis and its effects on various organs, particularly the heart
  • Distinguish between light-chain (AL) amyloidosis, wild type TTR amyloidosis and hereditary TTR amyloidosis in terms of their clinical manifestations and their different treatments
  • Recognise the novel challenges of managing heart failure in cardiac amyloidosis, including both medical management and the role of devices
  • Understand the critically important interaction between haematologists and cardiologists in the therapy of AL amyloidosis
  • Develop an understanding of novel therapies currently in clinical trials of TTR and AL amyloidosis
  • Identify their own roles and responsibilities in the management TTR and AL amyloidosis as part of a multidisciplinary team
See more

Most Recent

View All
Medical Options for Advanced HFpEF/HFmrEF Patients: An Expert-Guided Virtual Ward Round
  • 1.00 EBAC

Learning objectives

  • Describe the current limitations of HFmrEF/HFpEF GDMT in advanced patients
  • Select appropriate patients for advanced medical therapy
  • Recall recent trial data for novel therapeutic approaches
  • Use expert guidance to develop an evidence-based approach to managing advanced HFmrEF/HFpEF
See more
Bridging the Gap in Worsening Heart Failure: Evidence-Based Approaches to Optimising Treatment Outcomes
  • 1.25 AMA PRA Credit

Learning objectives

  • To identify high-risk patient features indicative of worsening Heart Failure (HF)
  • Name validated tools for serial prognostic assessment and risk stratification
  • Adopt the use of appropriate assessment tools during patient follow-up
  • Recall rates of recurrent HF events and their associated healthcare costs in worsening HF patients
  • Recall the clinical benefit of emerging treatments targeted to treating worsening HF
  • Initiate available treatment for the tailored management of worsening HF
See more